Find your path to Abdel
117 people in our graph share verified history with Abdel — schools, employers, funds. One of them is your warm intro.
William D. ProvineunlockedAbdel: together at DuPont (1992–1994)
×10Abdel: together at DuPont
Abdel: together at University of Tübingen
Executive at Matinas BioPharma Holdings
Co-founders at Matinas BioPharma Holdings
RR
Roelof RongenExecutive Officer, Director
JD
Jerome D. JabbourChairman, Chief Executive Officer and President
Experience
- Matinas BioPharmaCo-Founder and Executive VPcurrent2011 — presentBedminster, Nj
- DeMelle BioPharmaPresident and Foundercurrent2008 — present
- Reliant Pharmaceuticals, Inc.Head of Pharmaceutical Development2001 — 2008
- Ascent PediatricsDirector, Product Development1994 — 2001
- DuPontSr. Development Pharmacist1990 — 1994
Skills & more
Technology TransferResearchLifesciencesDrug DevelopmentCommercialization
From Abdel's professional profile.
Frequently asked questions
- Who is Abdel A. Fawzy?
- Executive Officer at Matinas BioPharma Holdings
- Where does Abdel A. Fawzy work?
- Abdel A. Fawzy is Executive at Matinas BioPharma Holdings.
- Where did Abdel A. Fawzy go to school?
- Abdel A. Fawzy studied at University of Tübingen (Ph.D., Pharmaceutical Technology).
Same school
Also attended University of Tübingen56
Isabell GollmerInvestment Manager at Seed+SpeedPaul-Josef PattFounding Partner at eCAPITAL ENTREPRENEURIAL PARTNERSSimon SchminckeGeneral Partner at CreandumJana PetryInvestment Manager at UVC PartnersMartin MünchbachManaging Partner at Pureos BioventuresUlrich KruseInvestment Manager at TRUMPF Venture
+ 50 more
Shared employers
Also worked at Matinas BioPharma3
Also worked at DuPont63
James MassaquoiSenior Investment Associate at Glasswing VenturesWilliam D. ProvinePresident & CEO at The Innovation SpaceNatalie EphraimProgram Manager – Mentorship & Partnerships at The Innovation SpaceTyler AmesEntrepreneur-In-Residence at The Innovation SpaceAlexander KhutorskyVice President, Mergers & Acquisitions at DuPont at The Innovation SpaceAlbert J. RobichaudPartner at Cure Ventures
+ 57 more